SLC16A1 and amyotrophic lateral sclerosis: Furthermore, it has been recently shown that the disruption of monocarboxylate transporter 1 present in oligodendroglia produces neuronal and axonal damage and that its expression is reduced in affected regions of ALS patients and mutant SOD1 (superoxide dismutase 1) mice (Lee et al., 2012).